Use of reporter genes for optical measurements of neoplastic disease in vivo

Neoplasia

Volumn 2, Issue 1-2, 2000, Pages 41-52

  Contag, Christopher H ^a,d   Jenkins, Darlene ^b   Contag, Pamela R ^a,b   Negrin, Robert S ^c  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Xenogen Corporation   (United States)

^d STANFORD UNIVERSITY   (United States)

Author keywords

CCD; Imaging; In vivo; Luciferase; Non invasive; Photon counting

Indexed keywords

GREEN FLUORESCENT PROTEIN; LACTATE DEHYDROGENASE; LUCIFERASE; NUCLEAR PROTEIN;

CARCINOGENESIS; HUMAN; IMAGING; NEOPLASM; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PHOTON; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REPORTER GENE; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TUMOR GROWTH;

EID: 0034005650     PISSN: 15228002     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.neo.7900079     Document Type: Review

References (92)

1. Clemens MJ, and Bommer UA (1999). Translational control: the cancer connection. Int J Biochem Cell Biol 31, 1-23.
2. Dang CV, and Semenza GL (1999). Oncogenic alterations of metabolism. Trend Biochem Sci 24, 68-72.
3. Devereux TR, Risinger JI, and Barrett JC (1999). Mutations and altered expression of the human cancer genes: what they tell us about causes. IARC Sci Publ, 19-42.
4. Holt SE, and Shay JW (1999). Role of telomerase in cellular proliferation and cancer. J Cell Physiol 180, 10-18.
5. Jacobson S, and Pillus L (1999). Modifying chromatin and concepts of cancer. Curr Opin Gen Dev 9, 175-184.
6. Markiewicz MA, and Gajewski TF (1999). The immune system as anti-tumor sentinel: molecular requirements for an anti-tumor immune response. Crit Rev Oncogen 10, 247-260.
7. McBurney MW (1999). Gene silencing in the development of cancer. Exp Cell Res 248, 25-29.
8. Kavanaugh DY, and Carbone DP (1996). Immunologic dysfunction in cancer. Hem/Oncol Clin N Am 10, 927-951.
9. Whiteside TL, and Herberman RB (1995). The role of natural killer cells in immune surveillance of cancer. Curr Opin Immunol 7, 704-710.
10. Christofori G, and Hanahan D (1994). Molecular dissection of multi-stage tumorigenesis in transgenic mice. Sem Cancer Biol 5, 3-12.
11. Hanahan D, and Folkman J (1996). Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86, 353-364.
12. Coussens LM, Hanahan D, and Arbeit JM (1996). Genetic predisposition and parameters of malignant progression in K14-HPV16 transgenic mice. Am J Pathol 149, 1899-1917.
13. Bigos M, Baumgarth N, Jager GC, Herman OC, Nozaki T, Stovel RT, Parks DR, and Herzenberg LA (1999). Nine color eleven parameter immunophenotyping using three laser flow cytometry. Cytometry 36, 36-45.
14. Brown PO, and Botstein D (1999). Exploring the new world of the genome with DNA microarrays. Nat Gen 21, 33-37.
15. Eisen MB, and Brown PO (1999). DNA arrays for analysis of gene expression. Methods Enzymol 303, 179-205.
16. Matz MV, Fradkov AF, Labas YA, Savitsky AP, Zaraisky AG, Markelov ML, and Lukyanov SA (1999). Fluorescent proteins from non-bioluminescent Anthozoa species. Nat Biotechnol 17, 969-973.
17. Perou CM, Jeffrey SS, van de Rijn M, Rees CA, Eisen MB, Ross DT, Pergamenschikov A, Williams CF, Zhu SX, Lee JC, Lashkari D, Shalon D, Brown PO, and Botstein D (1999). Distinctive gene expression patterns in human mammary epithelial cells and breast cancers. Proc Natl Acad Sci USA 96, 9212-9217.
18. Piston DW (1999). Imaging living cells and tissues by two-photon excitation microscopy. Trends Cell Biol 9, 66-69.
19. Pollack JR, Perou CM, Alizadeh AA, Eisen MB, Pergamenschikov A, Williams CF, Jeffrey SS, Botstein D, and Brown PO (1999). Genomewide analysis of DNA copy-number changes using cDNA microarrays. Nat Gen 23, 41-46.
20. Potter SM (1996). Vital imaging: two photons are better than one. Curr Biol 6, 1595-1598.
21. Zhang L, Hellstrom KE, and Chen L (1994). Luciferase activity as a marker of tumor burden and as an indicator of tumor response to antineoplastic therapy in vivo. Clin Exp Metastasis 12, 87-92.
22. Negrin RS, and Blume KG (1991). The use of the polymerase chain reaction for the detection of minimal residual malignant disease. Blood 78, 255-258.
23. Bogdanov A, Jr, and Weissleder R (1998). The development of in vivo imaging systems to study gene expression. Trends Biotechnol 16, 5-10.
24. Chenevert TL, McKeever PE, and Ross BD (1997). Monitoring early response of experimental brain tumors to therapy using diffusion magnetic resonance imaging. Clin Cancer Res 3, 1457-1466.
25. Ross B, Zhao Y-J, Neal E, Stegman L, Ercolani M, Ben-Yoseph O, and Chenevert T (1998). Contributions of cell kill and posttreatment tumor growth rates to the repopulation of intracerebral 9L tumors after chemotherapy: an MRI study. Proc Natl Acad Sci USA 95, 7012-7017.
26. Galons J-P, Altbach M, Paine-Murrieta G, Taylor C, and Gillies R (1999). Early increases in breast tumor xenograft water mobility in response to paclitaxel therapy detected by non-invasive diffusion magnetic resonance imaging. Neoplasia 1, 113-117.
27. Gambhir SS, Barrio JR, Herschman HR, and Phelps ME (1999). Imaging gene expression: principles and assays. J Nucl Cardiol 6, 219-233.
28. Gambhir SS, Barrio JR, Phelps ME, Iyer M, Namavari M, Satyamurthy N, Wu L, Green LA, Bauer E, MacLaren DC, Nguyen K, Berk AJ, Cherry SR, and Herschman HR (1999). Imaging adenoviral-directed reporter gene expression in living animals with positron emission tomography. Proc Natl Acad Sci USA 96, 2333-2338.
29. Jacobs A, Dubrovin M, Hewett J, Sena-Esteves M, Tan C-W, Slack M, Sadelain M, Breakefield X, and Tjuvajev J (1999). Functional coexpression of HSV-1 thymidine kinase and green fluorescent protein: implications for non-invasive imaging of transgene expression. Neoplasia 1, 154-161.
30. Tjuvajev JG, Finn R, Watanabe K, Joshi R, Oku T, Kennedy J, Beattie B, Koutcher J, Larson S, and Blasberg RG (1996). Non-invasive imaging of herpes virus thymidine kinase gene transfer and expression: a potential method for monitoring clinical gene therapy. Cancer Res 56, 4087-4095.
31. Tjuvajev JG, Avril N, Oku T, Sasajima T, Miyagawa T, Joshi R, Safer M, Beattie B, DiResta G, Daghighian F, Augensen F, Koutcher J, Zweit J, Humm J, Larson SM, Finn R, and Blasberg R (1998). Imaging herpes virus thymidine kinase gene transfer and expression by positron emission tomography. Cancer Res 58, 4333-4341.
32. Uehara H, Miyagawa T, Tjuvajev J, Joshi R, Beattie B, Oku T, Finn R, and Blasberg R (1997). Imaging experimental brain tumors with 1-aminocyclopentane carboxylic acid and alpha-aminoisobutyric acid: comparison to fluorodeoxyglucose and diethylenetriaminepentaacetic acid in morphologically defined tumor regions. J Cereb Blood Flow Metab 17, 1239-1253.
33. Weissleder R, Tung CH, Mahmood U, and Bogdanov A, Jr (1999). In vivo imaging of tumors with protease-activated near-infrared fluorescent probes. Nat Biotechnol 17, 375-378.
34. Tjuvajev JG, Joshi A, Callegari J, Lindsley L, Joshi R, Balatoni J, Finn R, Larson SM, Sadelain M, and Blasberg RG (1999). A general approach to the non-invasive imaging of transgenes using cis-linked herpes simplex virus thymidine kinase. Neoplasia 1, 315-320.
35. Harisinghani MG, Saini S, Weissleder R, Hahn PF, Yantiss RK, Tempany C, Wood BJ, and Mueller PR (1999). MR lymphangiography using ultrasmall superparamagnetic iron oxide in patients with primary abdominal and pelvic malignancies: radiographic-pathologic correlation. AJR Am J Roentgenol 172, 1347-1351.
36. Josephson L, Tung CH, Moore A, and Weissleder R (1999). High-efficiency intracellular magnetic labeling with novel superparamagnetic-Tat peptide conjugates. Bioconjugate Chem 10, 186-191.
37. Reynolds JS, Troy TL, Mayer RH, Thompson AB, Waters DJ, Cornell KK, Snyder PW, and Sevick-Muraca EM (1999). Imaging of spontaneous canine mammary tumors using fluorescent contrast agents. Photochem Photobiol 70, 87-94.
38. Nioka S, Yung Y, Shnall M, Zhao S, Orel S, Xie C, Chance B, and Solin L (1997). Optical imaging of breast tumor by means of continuous waves. Adv Exp Med Biol 411, 227-232.
39. de Wet JR, Wood KV, Helinski DR, and DeLuca M (1985). Cloning of firefly luciferase cDNA and the expression of active luciferase in Escherichia coli. Proc Natl Acad Sci USA 82, 7870-7873.
40. de Wet J, Wood K, DeLuca M, Helinski D, and Subramani S (1987). Firefly luciferase gene: structure and expression in mammalian cells. Mol Cell Biol 7, 725-737.
41. Sherf B, and Wood K (1994). Firefly luciferase engineered for improved genetic reporting. Promega Notes Mag 49, 14-21.
42. Wood KV (1995). Marker proteins for gene expression. Curr Opin Biotechnol 6, 50-58.
43. Hastings JW (1996). Chemistries and colors of bioluminescent reactions: a review. Gene 173, 5-11.
44. Willard ST, Faught WJ, and Frawley LS (1997). Real-time monitoring of estrogen-regulated gene expression in single, living breast cancer cells: a new paradigm for the study of molecular dynamics. Cancer Res 57, 4447-4450.
45. Chen H, Biel MA, Borges MW, Thiagalingam A, Nelkin BD, Baylin SB, and Ball DW (1997). Tissue-specific expression of human achaete-scute homologue-1 in neuroendocrine tumors: transcriptional regulation by dual inhibitory regions. Cell Growth Differ 8, 677-686.
46. Takakuwa K, Fujita K, Kikuchi A, Sugaya S, Yahata T, Aida H, Kurabayashi T, Hasegawa I, and Tanaka K (1997). Direct intratumoral gene transfer of the herpes simplex virus thymidine kinase gene with DNA-liposome complexes: growth inhibition of tumors and lack of localization in normal tissues. Jpn J Cancer Res 88, 166-175.
47. Grentzmann G, Ingram JA, Kelly PJ, Gesteland RF, and Atkins JF (1998). A dual-luciferase reporter system for studying recoding signals. RNA 4, 479-486.
48. Day RN, Kawecki M, and Berry D (1998). Dual-function reporter protein for analysis of gene expression in living cells. Biotechnology 25, 848-850.
49. Contag CH, Contag PR, Mullins JI, Spilman SD, Stevenson DK, and Benaron DA (1995). Photonic detection of bacterial pathogens in living hosts. Mol Microbiol 18, 593-603.
50. Contag C, Spilman S, Contag P, Oshiro M, Eames B, Dennery P, Stevenson D, and Benaron D (1997). Visualizing gene expression in living mammals using a bioluminescent reporter. Photochem Photobiol 66, 523-531.
51. Contag PR, Olomu IN, Stevenson DK, and Contag CH (1998). Bioluminescent indicators in living mammals. Nat Med 4, 245-247.
52. Sweeney T, Mailander V, Tucker A, Olomu AB, Zhang W, Negrin RS, and Contag CH (1999). Visualizing tumor cell clearance in living animals. Proc Natl Acad Sci USA 96, 12044-12049.
53. Edinger M, Sweeney TJ, Tucker AA, Adesuwa B Olomu AB, Negrin RS, and Contag CH (1999). Non-invasive assessment of tumor cell proliferation in animal models. Neoplasia 1, 303-310.
54. Chance B, Luo Q, Nioka S, Alsop DC, and Detre JA (1997). Optical investigations of physiology: a study of intrinsic and extrinsic biomedical contrast. Philos Trans R Soc London B Biol Sci 352, 707-716.
55. Koslowski JM, Fidler IJ, Campbel D, Xu Z, Kaigh ME, and Hart IR (1984). Metastatic behavior of human tumor cell lines grown in the nude mouse. Cancer Res 44, 3522-3529.
56. Cave H, van der Werff ten Bosch J, Suciu S, Guidai C, Waterkeyn C, Otten J, Bakkus M, Thielemans K, Grandchamp B, and Vilmer E (1998). Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia. European Organization for Research and Treatment of Cancer - Childhood Leukemia Cooperative Group. New Engl J Med 339, 591-598.
57. Hirsch-Ginsberg C (1998). Detection of minimal residual disease: relevance for diagnosis and treatment of human malignancies. Annu Rev Med 49, 111-122.
58. Uckun FM, Sather H, Reaman G, Shuster J, Land V, Trigg M, Gunther R, Chelstrom L, Bleyer A, and Gaynon P (1995). Leukemic cell growth in SCID mice as a predictor of relapse in high-risk B-lineage acute lymphoblastic leukemia. Blood 85, 873-878.
59. Arguello F, Sterry JA, Zhao YZ, Alexander MR, Shoemaker RH, and Cohen HJ (1996). Two serologic markers to monitor the engraftment, growth, and treatment response of human leukemias in severe combined immunodeficient mice. Blood 87, 4325-4332.
60. Schmidt-Wolf IGH, Negrin RS, Kiem HP, Blume KG, and Weissman IL (1991). Use of a SCID mouse/human lymphoma model to evaluate cytokine-induced killer cells with potent antitumor cell activity. J Exp Med 174, 139-149.
61. Lu PH, and Negrin RS (1994). A novel population of expanded human CD3+CD56+ cells derived from T cells with potent in vivo antitumor activity in mice with severe combined immunodeficiency. J Immunol 153, 1687-1696.
62. Ochoa AC, Gromo G, Alter BJ, Sondel PM, and Bach FH (1987). Long-term growth of lymphokine-activated killer LAK cells: role of anti-CD3, beta-IL 1, interferon-gamma and -beta. J Immunol 138, 2728-2733.
63. Schmidt-Wolf IG, Lefterova P, Johnston V, Scheffold C, Csipai M, Mehta BA, Tsuruo T, Huhn D, and Negrin RS (1996). Sensitivity of multidrug-resistant tumor cell lines to immunologic effector cells. Cell Immunol 169, 85-90.
64. Schmidt-Wolf IG, Lefterova P, Mehta BA, Fernandez LP, Huhn D, Blume KG, Weissman IL, and Negrin RS (1993). Phenotypic characterization and identification of effector cells involved in tumor cell recognition of cytokine-induced killer cells. Exp Hematol 21, 1673-1679.
65. Hoyle CH, Bangs CD, Cahng P, Kamel O, Mehta BA, and Negrin RS (1998). Expansion of Philadelphia-chromosome-negative CD3+ CD56+ cytotoxic cells from CML patients: in vitro and in vivo efficacy in SCID mice. Submitted.
66. Chishima T, Yang M, Miyagi Y, Li L, Tan Y, Baranov E, Shimada H, Moossa AR, Penman S, and Hoffman RM (1997). Governing step of metastasis visualized in vitro. Proc Natl Acad Sci USA 94, 11573-11576.
67. Chishima T, Miyagi Y, Wang X, Tan Y, Shimada H, Moossa A, and Hoffman RM (1997). Visualization of the metastatic process by green fluorescent protein expression. Anticancer Res 17, 2377-2384.
68. Brejc K, Sixma TK, Kitts PA, Kain SR, Tsien RY, Ormo M, and Remington SJ (1997). Structural basis for dual excitation and photoisomerization of the Aequorea victoria green fluorescent protein. Proc Natl Acad Sci USA 94, 2306-2311.
69. Cubitt AB, Heim R, Adams SR, Boyd AE, Gross LA, and Tsien RY (1995). Understanding, improving and using green fluorescent proteins. Trends Biochem Sci 20, 448-455.
70. Heim R, Prasher DC, and Tsien RY (1994). Wavelength mutations and posttranslational autoxidation of green fluorescent protein. Proc Natl Acad Sci USA 91, 12501-12504.
71. Heim R, Cubitt AB, and Tsien RY (1995). Improved green fluorescence. Nature 373, 663-664.
72. Tsien RY (1998). The green fluorescent protein. Annu Rev Biochem 67, 509-544.
73. Ormo M, Cubitt AB, Kallio K, Gross LA, Tsien RY, and Remington SJ (1996). Crystal structure of the Aequorea victoria green fluorescent protein. Science 273, 1392-1395.
74. Ito Y, Suzuki M, and Husimi Y (1999). A novel mutant of green fluorescent protein with enhanced sensitivity for microanalysis at 488 nm excitation. Biochem Biophys Res Commun 264, 556-560.
75. Yang M, Jiang P, Sun F, Hasegawa S, Baranov E, Chishima T, Shimada H, Moossa A, and Hoffman R (1999). A fluorescent orthotopic bone metastasis model of human prostate cancer. Cancer Res 59, 781-786.
76. Naumov G, Wilson S, MacDonald I, Schmidt E, Morris V, Groom A, Hoffman R, and Chambers A (1999). Cellular expression of green fluorescent protein, coupled with high-resolution in vivo videomicroscopy, to monitor steps in tumor metastasis. J Cell Sci 112, 1835-1842.
77. Fukumura D, Xavier R, Sugiura T, Chen Y, Park EC, Lu N, Selig M, Nielsen G, Taksir T, Jain RK, and Seed B (1998). Tumor induction of VEGF promoter activity in stromal cells. Cell 94, 715-725.
78. Yang M, Hasegawa S, Jiang P, Wang X, Tan Y, Chishima T, Shimada H, Moossa A, and Hoffman R (1998). Widespread skeletal metastatic potential of human lung cancer revealed by green fluorescent protein expression. Cancer Res 58, 4217-4221.
79. Hoffman R (1999). Orthotopic transplant mouse models with green fluorescent protein-expressing cancer cells to visualize metastasis and angiogenesis. Cancer Met Rev 17, 271-277.
80. Hofmann B, Bogdanov A, Jr, Marecos E, Ebert W, Semmler W, and Weissleder R (1999). Mechanism of gadophrin-2 accumulation in tumor necrosis. J Magn Reson Imaging 9, 336-341.
81. Fillmore HL, Shurm J, Furqueron P, Prabhu SS, Gillies GT, and Broaddus WC (1999). An in vivo rat model for visualizing glioma tumor cell invasion using stable persistent expression of the green fluorescent protein. Cancer Lett 141, 9-19.
82. MacDonald TJ, Tabrizi P, Shimada H, Zlokovic BV, and Laug WE (1998). Detection of brain tumor invasion and micrometastasis in vivo by expression of enhanced green fluorescent protein. Neurosurgery 43, 1437-1442.
83. Moore A, Marecos E, Simonova M, Weissleder R, and Bogdanov A, Jr (1998). Novel gliosarcoma cell line expressing green fluorescent protein: a model for quantitative assessment of angiogenesis. Microvase Res 56, 145-153.
84. Kajiyama N, and Nakano E (1991). Isolation and characterization of mutants of firefly luciferase which produce different colors of light. Protein Eng 4, 691-693.
85. Wood KV, Lam YA, Seliger HH, and McElroy WD (1989). Complementary DNA coding click beetle luciferases can elicit bioluminescence of different colors. Science 244, 700-702.
86. Wood KV, Lam YA, and McElroy WD (1989). Introduction to beetle luciferases and their applications. J Biolumin Chemilumin 4, 289-301.
87. Wood KV (1990). Luc genes: introduction of colour into bioluminescence assays. J Biolumin Chemilumin 5, 107-114.
88. Eames BF, Benaron DA, Stevenson DK, and Contag CH (1999). Construction and in vivo testing of a red-emitting firefly luciferase. Proceedings of SPIE Annual Meeting. SPIE, pp. 36-39.
89. Stables J, Scott S, Brown S, Roelant C, Burns D, Lee MG, and Rees S (1999). Development of a dual glow-signal firefly and Renilla luciferase assay reagent for the analysis of G-protein-coupled receptor signalling. J Recept Signal Transduction Res 19, 395-410.
90. Chalfie M, Tu Y, Euskirchen G, Ward WW, and Prasher DC (1994). Green fluorescent protein as a marker for gene expression. Science 263, 802-805.
91. Chalfie M (1995). Green fluorescent protein. Photochem Photobiol 62, 651-656.
92. Heim R, and Tsien RY (1996). Engineering green fluorescent protein for improved brightness, longer wavelengths and fluorescence resonance energy transfer. Curr Biol 6, 178-182.